• <em>Modus operandi</em> of ClC-K2 Cl^- Channel in the Collecting Duct Intercalated Cells
• A clinical and hereditary analysis of novel complex heterozygous <em>KCNJ1</em> mutation in a Bartter syndrome type Ⅱ patient
• A mosaic mutation in the <em>CLCNKB</em> gene causing Bartter syndrome: A case report
• A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report
• A novel CLCNKB variant in a Chinese family with classic Bartter syndrome and prenatal genetic diagnosis
• A novel homozygous CLCNKB variant: An early presentation of classic Bartter syndrome in a neonate
• A novel mutation associated with Type III Bartter syndrome: A report of five cases
• A novel SLC12A1 mutation in Bedouin kindred with antenatal Bartter syndrome type I
• Acquired Bartter-like Syndrome Presenting with Polyuria and Reversible Hypokalemia Associated with Colistin Use in a Critically Ill Pediatric Patient
• Acute kidney injury in type 3 Bartter syndrome: Angiotensin-converting enzyme inhibitors as a cause
• Adult classic Bartter syndrome: a case report with 5-year follow-up and literature review
• Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia
• Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases
• Antenatal Bartter syndrome presenting with vomiting and constipation mimicking subacute intestinal obstruction in a 20-day-old neonate
• Antenatal Bartter syndrome: a new compound heterozygous mutation in exon 2 of KCNJ1 gene
• Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism
• Association of Mucopolysaccharidosis Type 4A and Bartter Syndrome
• Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations
• Bartter syndrome in two sisters with a novel mutation of the CLCNKB gene, one with deafness
• Bartter syndrome type 3 in an elderly complicated with adrenocorticotropin-deficiency
• Bartter Syndrome Type 3: Phenotype-Genotype Correlation and Favorable Response to Ibuprofen
• Bartter syndrome type III and congenital anomalies of the kidney and urinary tract: an antenatal presentation
• Bartter syndrome type III with only a synonymous mutation of the <em>CLCNKB</em> gene

• Bartter Syndrome-Related Variants Distribution: Brazilian Data and Its Comparison with Worldwide Cohorts
• Bartter syndrome, severe rare orphan kidney disease: a step towards therapy through pharmacogenetic and epidemiological studies
• Calcitonin gene-related peptide, heme oxygenase-1, endothelial progenitor cells and nitric oxide-dependent vasodilation relationships in a human model of angiotensin II type-1 receptor antagonism
• Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism
• Calcium-sensing receptor: Role in health and disease
• Chronic pancreatitis with type V Bartter syndrome: An unusual presentation
• Classic Bartter Syndrome: A Cause of Severe Hypokalemic Metabolic Alkalosis
• ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3
• CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2+ dependence of ClC-Kb channels
• Clinical and gene mutation features of cystic fibrosis: an analysis of 8 cases
• Clinical and Genetic Spectrum of Bartter Syndrome Type 3
• Clinical characteristics of HNF1B-related disorders in a Japanese population
• Clinical Findings and Genetic Analysis of Nine Mexican Families with Bartter Syndrome
• Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation
• Co-Existence of Congenital Adrenal Hyperplasia and Bartter Syndrome due to Maternal Uniparental Isodisomy of HSD3B2 and CLCNKB Mutations
• Congenital chloride diarrhea misdiagnosed as Bartter syndrome
• Contradiction between genetic analysis and diuretic loading test in type I Bartter syndrome: a case report
• Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics
• Diseases associated with calcium-sensing receptor
• Diverse genotypical features and impacts on clinical course and severity of cystic fibrosis: early childhood experience
• Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome
• Eight novel KCNJ1 variants and parathyroid hormone overaction or resistance in 5 probands with Bartter syndrome type 2
• Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I
• Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II
• Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome
• Factors Associated with Infant Feeding Methods after the Nuclear Power Plant Accident in Fukushima: Data from the Pregnancy and Birth Survey for the Fiscal Year 2011 Fukushima Health Management Survey
• Functional characterization of SLC12A1 gene variants in 3 patients with Bartter syndrome type Ⅰ
• Genetic heterogeneity in patients with Bartter syndrome type 1
• Genetics of type III Bartter syndrome in Spain, proposed diagnostic algorithm
• Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3
• Gitelman or Bartter type 3 syndrome? A case of distal convoluted tubulopathy caused by CLCNKB gene mutation
• Hereditary renal tubular disorders in Turkey: demographic, clinical, and laboratory features
• Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome: A Family Report
• Hypokalemia and hearing loss in a 3-year-old boy: Questions
• Hypokalemia in a young manthink Bartter syndrome type 3
• Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome
• Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes
• Identification of missense mutation (I12T) in the BSND gene and bioinformatics analysis
• In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening
• Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients
• Inherited salt-losing tubulopathy: An old condition but a new category of tubulopathy
• Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel
• Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions
• Loss of sodium chloride co-transporter impairs the outgrowth of the renal distal convoluted tubule during renal development
• Mimicry and well known genetic friends: molecular diagnosis in an Iranian cohort of suspected Bartter syndrome and proposition of an algorithm for clinical differential diagnosis
• Monogenic urinary lithiasis in Tunisian children: 25 years' experience of a referral center
• New perspective of ClC-Kb/2 Cl- channel physiology in the distal renal tubule
• Osteomalacia in a Case of Adult-Onset Bartter Syndrome
• Paradoxical hypertension and salt wasting in Type II Bartter syndrome
• Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research
• Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome
• Rare diseases caused by abnormal calcium sensing and signalling
• Regulation of kidney on potassium balance and its clinical significance
• Renal Cysts and Nephrocalcinosis in a Patient Deficient in 11 beta-Hydroxylase Enzyme
• Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene
• Severe early onset hydramnios in a singleton pregnancy due to antenatal Bartter syndrome
• Severe hypocalcaemia episodes in a patient of primary hypoparathyroidism precipitated by underlying stress due to haemophagocytic lymphohistiocytosis (HLH) secondary to pulmonary tuberculosis
• Simultaneous Homozygous Mutations in <em>SLC12A3</em> and <em>CLCNKB</em> in an Inbred Chinese Pedigree
• SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension
• Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?
• SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation
• Splicing Characterization of <em>CLCNKB</em> Variants in Four Patients With Type III Bartter Syndrome
• Tacrolimus ameliorates the phenotypes of type 4 Bartter syndrome model mice through activation of sodium-potassium-2 chloride cotransporter and sodium-chloride cotransporter
• The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing
• The Urinary Excretion of Uromodulin is Regulated by the Potassium Channel ROMK
• Thirteen novel CLCNKB variants and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3
• Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice
• Two Brothers from Macedonia with Gitelman Syndrome
• Two novel mutations in the <em>CLCNKB</em> gene leading to classic Bartter syndrome presenting as syncope and hypertension in a 13-year-old boy
• Type 3 antenatal Bartter syndrome presenting with mild polyuria
• Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
• Understanding Bartter syndrome and Gitelman syndrome
• Unusual case of failure to thrive: Type III Bartter syndrome
• Urinary bladder hypertrophy characteristic of male ROMK Bartter's mice does not occur in female mice
• Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes
• Whole Exome Sequencing Reveals CLCNKB Mutations in a Case of Sudden Unexpected Infant Death
• Whole-Exome Sequencing Reveals CLCNKB Mutations in a Case of Sudden Unexpected Infant Death